Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Fulvenat 250mg Injection (fulvestrant), a selective estrogen receptor antagonist used for the treatment and management of hormone receptor-positive breast cancer in postmenopausal women. It works by blocking the action of estrogen on cancer cells, thereby slowing or stopping their growth. This medicine is administered as an intramuscular injection by a trained healthcare professional.
| Strength | 250mg/Vial |
| Uses | Hormone-receptor-positive breast cancer |
| Storage | refrigerator (2°C to 8°C) |
| Route of Administration | Intramuscular |
| Pack Size | 250mg / Vial |
| Main Ingredients | Fulvestrant (250mg) |